Taysha Gene Therapies, Inc. (TSHA)
NASDAQ: TSHA · Real-Time Price · USD
5.66
-0.23 (-3.90%)
Jun 5, 2026, 12:24 PM EDT - Market open

Taysha Gene Therapies Analyst Ratings

Ratings History

AnalystFirmRatingRatingActionPrice TargetUpsideDate
BMO Capital
BMO Capital
Buy
Reiterates
$10
BuyReiterates$10+76.68%May 22, 2026
Unknown Analyst
Bank of America Securities
No rating
Bank of America Securities
Buy
Reiterates
$9
BuyReiterates$9+59.01%May 8, 2026
Canaccord Genuity
Canaccord Genuity
Buy
Maintains
$17
BuyMaintains$17+200.35%May 7, 2026
Unknown Analyst
Wells Fargo
No rating
Wells Fargo
Buy
Maintains
$11
BuyMaintains$11+94.35%May 7, 2026
Chardan Capital
Chardan Capital
Buy
Reiterates
$12
BuyReiterates$12+112.01%May 6, 2026
Needham
Needham
Buy
Reiterates
$12
BuyReiterates$12+112.01%May 6, 2026
Cantor Fitzgerald
Cantor Fitzgerald
Buy
Maintains
$19
BuyMaintains$19+235.69%Mar 25, 2026
Unknown Analyst
Jefferies
No rating
Jefferies
Buy
Maintains
$13
BuyMaintains$13+129.68%Mar 20, 2026

Upgrade to Pro

Get stock forecasts from Wall Street's highest rated professionals

Get much more with Stock Analysis Pro

  • Investment ideas from the top Wall Street analysts
  • Unlimited access to all data and tools
  • Advanced analyst filtering and sorting options
  • Up to 3 years of analyst rating history
Sign Up Today

Analyst Star Rankings

Our analyst star rankings are based on these four factors

Success Rate
The percentage of ratings that are profitable.
Average Return
The average percentage return within one year of the rating.
Rating Count
The more ratings the analyst has provided, the higher the score.
Recency
Ratings provided within the past year contribute to a higher score.